Richard Angell

Oct 16, 2024 | fabians.org.uk | Richard Angell |Oliver Walsh |Natalie Perera

Across the Board by Richard AngellUniversal A&E screening can protect the most vulnerable and save the NHS money When Labour was last in government, it adopted an approach that might be termed progressive universalism: it improved services for all, but prioritised services for the poorest, disadvantaged and those experiencing inequalities. Sure Start, Building Schools for the Future and city academies all started in areas of deprivation before being deployed to rebuild the public realm for all.

Jul 4, 2024 | tht.org.uk | Richard Angell

Text'There can be no complacency in our endeavour to end this epidemic.' Not my words, but those of Sir Keir Starmer when he addressed a room of MPs, charities and people living with HIV on World AIDS Day last year. At an event in honour of Sir Elton John, the Labour leader committed that a government in his name would commission a new HIV Action Plan within 100 days if elected. Fast forward seven months, and Starmer is entering Downing Street at a crucial moment for HIV.

Apr 4, 2024 | tht.org.uk | Richard Angell

TextToday marks 12 months since the full and final recommendations on compensation was published by the Infected Blood Inquiry. For victims of the ‘worst treatment disaster in the history of the NHS’ and this five-decade long struggle for truth and justice that has ravaged those infected with HIV and other viruses as a result of contaminated blood products, it is another anniversary to add to their list.

Feb 15, 2024 | gaytimes.co.uk | Alice Morey |Richard Angell |Sam Damshenas

Originals From cast members to plot points, here’s everything we know (so far) about The History of Sound.

Feb 11, 2024 | nature.com | Ahmed Ahmed |Richard Angell |Shozeb Haider

AbstractThe tetrasubstituted naphthalene diimide compound QN-302 binds to G-quadruplex (G4) DNA structures. It shows high potency in pancreatic ductal adenocarcinoma (PDAC) cells and inhibits the transcription of cancer-related genes in these cells and in PDAC animal models. It is currently in Phase 1a clinical evaluation as an anticancer drug. A study of structure–activity relationships of QN-302 and two related analogues (CM03 and SOP1247) is reported here.